Company Filing History:
Years Active: 2018-2024
Title: The Innovations of Adrianus Cornelis Van Der Graaf
Introduction
Adrianus Cornelis Van Der Graaf is a notable inventor based in Groningen, Netherlands. He has made significant contributions to the field of medicinal chemistry, particularly in the development of medicaments for treating vasoconstriction-related diseases. With a total of 8 patents to his name, his work has the potential to impact the medical community positively.
Latest Patents
Van Der Graaf's latest patents focus on innovative medicaments aimed at treating vasoconstriction-related disorders. One of his key inventions involves the (2R) enantiomeric form of a 6-chromanol derivative, which is designed for prophylaxis or treatment of these conditions. This includes derivatives such as (6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)(piperazin-1-yl)methanone and N-(benzyl)-6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxamide, among others. Additionally, he has developed the (S) enantiomeric form of certain 6-chromanol derivatives for use as a medicament, showcasing his commitment to advancing therapeutic options.
Career Highlights
Throughout his career, Van Der Graaf has worked with various companies, including Sulfateq B.V. and Citeq B.V. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in medicinal chemistry.
Collaborations
Some of his notable coworkers include Gerrit Jan Willem Euverink and Robert Henk Henning. Their collaborative efforts have likely played a role in the successful development of his innovative patents.
Conclusion
Adrianus Cornelis Van Der Graaf's contributions to the field of medicinal chemistry are noteworthy. His innovative patents and collaborations reflect his dedication to improving treatments for vasoconstriction-related disorders. His work continues to inspire advancements in medical science.